What is Rekovelle 36 µg/1.08 ml inj. sol. s.c. pre-filled pen used for?

( ARTG ) Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.

What are the side effects of Rekovelle 36 µg/1.08 ml inj. sol. s.c. pre-filled pen?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Rekovelle 36 µg/1.08 ml inj. sol. s.c. pre-filled pen be used during pregnancy?

( AHT ) For the active ingredient follitropin delta You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Who manufactures Rekovelle 36 µg/1.08 ml inj. sol. s.c. pre-filled pen?

Ferring Pharmaceuticals a.s. (BE)

What ATC class does Rekovelle 36 µg/1.08 ml inj. sol. s.c. pre-filled pen belong to?

Rekovelle 36 µg/1.08 ml inj. sol. s.c. pre-filled pen: ATC G03GA10 Follitropin Delta. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Rekovelle 36 µg/1.08 ml inj. sol. s.c. pre-filled pen

Solution for injection in pre-filled pen

INN: Human Follitropin Delta, Recombinant

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧

Form

Solution for injection in pre-filled pen

Dosage

—

Route

Subcutaneous use

Storage

—

About This Product

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.